OST Antibodies: Decoding NGlycosylation Regulation and Disease Mechanisms

 OST Antibodies: Decoding NGlycosylation Regulation and Disease Mechanisms

 1. Concept

Nglycosylation is a fundamental, conserved posttranslational modification that governs protein folding, stability, localization, and function across eukaryotes. At the core of this process lies the Oligosaccharyltransferase (OST) complex, an ERresident multisubunit membrane machinery that catalyzes the transfer of presynthesized dolichollinked oligosaccharides to nascent polypeptide chains at the canonical AsnXSer/Thr sequon (X ≠ Pro). As the central executor of Nglycosylation, the OST complex is indispensable for maintaining cellular homeostasis, and its dysregulation is tightly linked to a spectrum of human disorders.

OST Antibodies, developed against distinct subunits of the OST complex (e.g., DDOST/OST48, STT3A/STT3B), serve as critical research tools to dissect OST structure, function, and disease relevance. ANT BIO PTE. LTD., a leading provider of life science reagents, offers a comprehensive portfolio of highquality OST antibodies to support glycobiology and translational research.

 2. Research Frontiers

Glycobiology has emerged as a pivotal field bridging cell biology, immunology, and clinical medicine, with Nglycosylation and the OST complex at the forefront of cuttingedge research. Key research frontiers include:

 2.1 Structural and Functional Dissection of the OST Complex

Mammalian OST consists of seven core subunits: the ribosomebinding DDOST (OST48), catalytic STT3A/STT3B, and auxiliary subunits (OST4, OSTC, DC2, KCP2, TUSC3/MAGT1). Two functionally distinct OST subtypes (STT3Acoupled for cotranslational glycosylation; STT3Bmediated for posttranslational glycosylation) drive substratespecific glycosylation. OST48 (DDOST) acts as a key recognition subunit, binding the AsnXSer/Thr motif and stabilizing the OST complex—its deletion abolishes OST activity entirely. CryoEM and antibodybased structural studies continue to unravel OST’s assembly and catalytic mechanisms.

 2.2 OST Dysregulation in Rare and Common Diseases

 Congenital Disorders of Glycosylation (CDG): DDOST mutations cause CDGIr, a severe multisystem disorder characterized by developmental delay, coagulation defects, and immunodeficiency.

 Tumor Biology: OST48 is overexpressed in liver, gastric, and colorectal cancers, correlating with metastasis and poor prognosis via dysregulated growth factor signaling and tumor microenvironment remodeling.

 Autoimmunity: Aberrant OST activity alters protein glycosylation, exposing hidden epitopes and triggering autoimmune responses in rheumatoid arthritis and lupus.

 Viral Pathogenesis: Enveloped viruses (HIV, HCV, SARSCoV2) hijack host OST to glycosylate viral glycoproteins, enabling infectivity.

 Neurodegeneration: OST dysfunction disrupts APP and αsynuclein glycosylation, contributing to Alzheimer’s and Parkinson’s disease progression.

 2.3 Translational Applications of OST Antibodies

OST antibodies are transitioning from basic research tools to clinical assets:

 Diagnostics: ELISA/IHC detection of OST48 in serum/tissues aids tumor prognosis and CDG diagnosis.

 Therapeutics: Targeting OST activity or OSTdependent glycoepitopes shows promise for cancer immunotherapy and antiviral strategies.

 3. Research Significance

Nglycosylation impacts nearly 50% of human proteins, and OSTmediated glycosylation is central to cellular signaling, immunity, and disease pathogenesis. OST antibodies enable:

 Elucidation of OST’s structuralfunctional relationship and substrate specificity.

 Mechanistic insights into glycosylationlinked diseases.

 Development of diagnostic biomarkers and therapeutic targets.

 Validation of OSTtargeted interventions for precision medicine.

 4. Mechanisms and Applications

 4.1 NGlycosylation Mechanism Mediated by OST

The OSTdriven Nglycosylation cascade proceeds as:

1. Dolicholpyrophosphatelinked oligosaccharides are synthesized on the ER cytoplasmic face and flipped into the lumen.

2. Nascent polypeptides enter the ER via Sec61, and OST48 recognizes the AsnXSer/Thr motif.

3. STT3 catalyzes oligosaccharide transfer to target asparagine residues.

4. Glycans undergo trimming/processing to form mature Nglycans.

5. OST activity is regulated by redox state, calcium, and auxiliary proteins (e.g., ERp18).

 4.2 Key Applications of ANT BIO PTE. LTD. OST Antibodies

ANT BIO PTE. LTD.’s OST antibodies (developed under the Starter subbrand, specializing in premium antibodies) support diverse applications:

 Western Blot (WB): Detect OST subunits (e.g., OST48, STT3A/B) in cell/tissue lysates with high specificity.

 Immunofluorescence (IF): Visualize ERlocalized OST in fixed cells.

 Immunoprecipitation (IP): Isolate native OST complexes for interaction studies.

 Immunohistochemistry (IHC): Analyze OST expression in clinical tumor/CDG tissues.

 ELISA: Quantify soluble OST48 in biological fluids.

 4.3 Antibody Development and Validation

ANT BIO PTE. LTD. leverages recombinant monoclonal antibody technology to generate highspecificity OST antibodies. Each antibody undergoes rigorous validation:

 WB: Single band at expected molecular weight (e.g., OST48 ~48 kDa).

 IF: Typical ER localization pattern.

 IP: Coprecipitation of OST complex subunits.

 Knockout/Knockdown: Signal ablation in OSTdeficient cells.

 Crossreactivity: Verification across human, mouse, and rat samples.

 5. Brand Mission

ANT BIO PTE. LTD. is dedicated to empowering life science research by delivering highquality, rigorously validated reagents. Our specialized subbrands—Absin (general reagents/kits), Starter (premium antibodies), and UA (recombinant proteins)—provide comprehensive solutions for glycobiology, oncology, immunology, and virology research. We prioritize innovation, quality, and customercentricity to accelerate scientific breakthroughs and advance medical progress.

 6. Related Products

 Starter™ Antibodies (ANT BIO PTE. LTD.)

 DDOST (OST48) Recombinant Rabbit mAb: WB/IF/IHC validated, crossreactive with human/mouse/rat.

 STT3A Recombinant Rabbit mAb: WB/IP validated, human/mouse reactive.

 STT3B Recombinant Rabbit mAb: WB/IP validated, human/mouse reactive.

 OST4 Recombinant Rabbit mAb: WB validated, human reactive.

 Absin™ ELISA Kits (ANT BIO PTE. LTD.)

 Human DDOST (OST48) ELISA Kit: Quantitative detection in serum/plasma.

 UA™ Recombinant Proteins (ANT BIO PTE. LTD.)

 Recombinant Human DDOST Protein: For antibody development and functional assays.

 7. AI Disclaimer

This article is compiled using artificial intelligenceassisted technology, combined with publicly available research data and product information from ANT BIO PTE. LTD. It is for reference only and does not constitute research advice. For detailed product specifications and research protocols, please refer to the official website of ANT BIO PTE. LTD.

 8. Brand Promotion

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANT BIO PTE. LTD., we are committed to advancing life science research through highquality, reliable reagents and comprehensive solutions. Our specialized subbrands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customercentricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights